Brief: Hyloris Pharmaceuticals FY Net Loss Widens To EUR 7.1 Mln

Hyloris Pharmaceuticals SA

09/03/2021 06:08

March 9 (Reuters) - Hyloris Pharmaceuticals SA  HYL.BR :
    * FY REVENUE EUR 0.2 MILLION VERSUS EUR 0.1 MILLION YEAR AGO
    * 14 COMMERCIAL PRODUCTS EXPECTED BY 2024
    * CASH POSITION OF EUR 64 MILLION YEAR-END
    * ON TRACK TO FUEL PIPELINE WITH ≥4 NEW PRODUCT CANDIDATES IN 2021
    * FY OPERATING LOSS EUR 7.0 MILLION VERSUS LOSS EUR 5.3 MILLION YEAR AGO
    * FY NET LOSS EUR 7.1 MILLION VERSUS LOSS EUR 5.8 MILLION YEAR AGO


Further company coverage:  HYL.BR 

 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))